Cardiology Headline News

Millions of U.S. adults may not fit within the range of arm sizes eligible for accurate readings with some of the most popular home blood pressure cuffs on the market, researchers reported.

The 2024 election is one of the most consequential elections in recent history, and as physicians, we have a responsibility to vote.

Philips announced the FDA approved the 160 cm version of its endovascular navigation wire that uses fiber optic technology.

Higher levels of life satisfaction and well-being may portend lower rates of CVD due to the association between inflammatory markers and CV risk factors observed among individuals reporting lower well-being, researchers reported.

Few areas in medicine have been impacted by AI as much as cardiac electrophysiology. While still in early stages, it is already influencing how electrophysiologists detect disease and predict outcomes.

Most physicians and residents report feelings of burnout, while stigma about receiving mental health care remains prevalent, according to a new report from The Physicians Foundation.

Boston Scientific announced it received FDA approval to expand the indication for its pacing leads to include conduction system pacing of the left bundle branch area when connected to a single- or dual-chamber pacemaker.

Remote BP monitoring and collaborative telehealth visits with a pharmacist improved BP control among patients at rural nephrology clinics and reduced hospitalization, a speaker reported.

Adults who drink caffeinated beverages such as coffee or tea may have a lower risk for developing multiple cardiometabolic diseases compared with adults with low or no intake, according to study findings.

Many recently recalled cardiovascular devices did not undergo premarket testing prior to FDA approval, and postmarket studies of the devices were slow and infrequent, researchers reported.